Lab Group Hires Lawyers to Parry FDA Regulation; AMA-led Groups Push for Rulemaking | GenomeWeb

NEW YORK (GenomeWeb) – The nation's top lab industry group is mulling legal strategies as part of its overall push to thwart regulation of laboratory-developed tests (LDTs) by the US Food and Drug Administration.

The American Clinical Laboratory Association announced today that it has retained Solicitor General Paul Clement, a partner at Bancroft PLLC, and Laurence Tribe, constitutional law professor at Harvard University, for "representation on matters relating to the FDA's recently issued draft guidance to regulate LDTs as medical devices."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.